Gianluigi Savarese is an expert in Cardiology at Karolinska Institute (Sweden). As of October 2026, ScienceLeadR ranks Gianluigi Savarese in the top 1% of experts worldwide for Heart Failure, and in the top 1% of experts in Sweden for Iron Deficiencies and Iron Metabolism Disorders. Gianluigi Savarese has authored 563 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 2 of them ongoing. SLR score: 2,498 (community average: 125). How the SLR is computed.

LeadR Profile

Gianluigi Savarese Karolinska Institute Sweden
2 498 ScienceLeadR Reputation 2498
Network Map

Cardiology

Subspecialties: Public Health - Endocrinology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Gianluigi Savarese is an Italian/Swedish cardiologist, currently Professor of Cardiology at Karolinska Institutet (Department of Clinical Science and Education) where he is head of the Center for Heart Failure and Arrhythmia. He is also Senior Consultant for Heart Failure at the Southern Hospital, Stockholm, Sweden. Over the last few years, he has published >400 articles on top peer reviewed journals. Major focus of his research is heart failure, with a particular interest in implementing use of guidelines recommended treatments, and phenotyping heart failure for improving clinical trial design. He is heavily involved in registry studies (Swedish Heart Failure Registry, ESC registries) and clinical trials, and he is expert in big data analysis. He is Secretary of the Heart Failure Association and he has served as board member and secretary of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. Among others, he is Deputy Editor of European Journal of Heart Failure, EHJ-Open, and Associate Editor of JACC: Heart Failure.

Organizations

Career arc: 2012 - 2026

Source: PubMed

Karolinska Institute

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 563

Citations

Citations: 20 236 1st author: 95 Last author: 113 Unique author: 5


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Heart failure management and outcomes: what can we learn from Japan?
PMID 42920285 — heart failure, heart
Eur Heart J Top journal20260
"Baseline Characteristics and Utilization of Medical Therapies in Acute Hospitalized and Chronic Heart Failure Patients Enrolled in GRASP-HF: Differences Between ICARe-HF and Non-ICARe-HF Centres".
PMID 42867408 — mortality, heart failure, heart, hospital mortality, heart failure, systolic, therapeutics
Eur J Heart Fail20260
Persistent C-reactive protein elevation and incident heart failure in adults at increased cardiovascular risk: A multinational electronic health record study.
PMID 42749086 — mortality, heart failure, heart, c-reactive protein, cardiology, electronic health records, risk factors, records
Int J Cardiol20261
Pharmacological treatment strategies to prevent heart failure across the cardiovascular-kidney-metabolic spectrum: an EJHF Expert Consensus Statement.
PMID 42817848 — kidney diseases, heart failure, heart, kidney, therapeutics
Eur J Heart Fail20260
What's New in Heart Failure? September 2026.
PMID 42817850 — heart failure, heart
Eur J Heart Fail20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 4
Phase 2/Phase 3 1
Phase 3 1
Phase 4 1

By status:

Completed 4
Recruiting 3

By type:

Interventional 4
Observational 3

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 1
multicentricup10 4

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy
2025-522553-19-00 — exercise, cardiomyopathy, dilated, safety, cardiomyopathies
Phase 2/Phase 3Recruiting2026
Registry BAsed Optimization Of Therapy in Heart Failure
NCT07154758 — registries, heart failure, pharmaceutical preparations, heart, mass screening, ambulatory care facilities, heart failure, systolic, therapeutics, outpatients
N/ARecruiting2024

LeadR Networks

Main global connection map